Status:
COMPLETED
Pill Swallow Study
Lead Sponsor:
RANI Therapeutics
Conditions:
Not Determined
Eligibility:
All Genders
21-75 years
Phase:
NA
Brief Summary
A prospective, single-center, open-label, single-arm, observational study assessing participant experience with swallowing the Mock-RP
Eligibility Criteria
Inclusion
- Participant age is 21 - 75 years
- Participant understands the nature of the study, is willing to comply with protocol defined evaluations, and provide written informed consent
- Participant currently taking injections to treat a chronic disorder
- Non-pregnant, non-lactating female NOTE: Females who are of childbearing potential must have had a negative pregnancy test on day of screening
Exclusion
- Active case of COVID-19
- History of Dysphagia
- History of dementia (e.g., Alzheimer's, vascular dementia, dementia with Lewy bodies, etc.)
- Participant self-reports issues with swallowing pills.
- History of drug or alcohol abuse or any other factor that, in the Investigator's opinion, may interfere with the participant's ability to cooperate and comply with the study procedures
- History of allergic reaction to a component of the Mock-RP
- History which, in the investigator's judgement, makes the participant ineligible or exposes the participant to unacceptable risks
Key Trial Info
Start Date :
June 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 27 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04911296
Start Date
June 1 2021
End Date
August 27 2021
Last Update
February 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Trials of Texas
San Antonio, Texas, United States, 78229